Used in pharmaceutical research as a chiral building block for the synthesis of bioactive molecules. It serves as a key intermediate in the development of drugs targeting neurological disorders, such as dopamine receptor modulators. Its bromophenyl group enhances binding affinity to specific receptors, while the pyrrolidine ring contributes to structural stability. This compound is also explored in the creation of potential treatments for psychiatric conditions due to its ability to interact with central nervous system targets. Additionally, it is utilized in asymmetric synthesis to produce enantiomerically pure compounds for therapeutic applications.